Consumers survey results of for 1 quarter of 2024 in category
Digestive system and hepatology / The medication for the treatment of intestinal infections
The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.
I quarter (january—march)
II quarter (april—june)
III quarter (july—september)
IV quarter (october—december)
1.
Enterosgelum (Kreoma-Pharm)
50.00%
5
1.
Нифуроксазид (Ternopharm)
50.00%
5
3.
Буларді МАКС (Delta Medical)
25.00%
2.50
3.
Лактофільтрум-еко (AVVA)
25.00%
2.50
3.
Нифуроксазид (Gedeon Richter)
25.00%
2.50
–.
Atoxil (Orisil-Pharm)
0.00%
0
–.
Ентерол (Біокодекс Україна)
0.00%
0
–.
Фталазол (Darnitsa)
0.00%
0
–.
Фталазол (Lab. Ofichem)
0.00%
0
–.
Фталазол-Здоров’я (Pharmaceutical company “Zdorovya”)
0.00%
0
–.
Фталазол-КМП (Arterium Corporation)
0.00%
0
This rating reflects the current interim results of the study of public opinion as on 10/02/2024 1:23:05 and it’s not yet final.
Strictly prohibited any use and reproduction of unfinished voting results without link to the source, without clear
explanation of the methodology of the “Favorites of Success” Contest and without mandatory
notes that poll is still continues and this result is not yet final.